Literature DB >> 2268506

Prostaglandin E2 inhibits and indomethacin enhances noradrenaline release in isolated kidneys of adult spontaneously hypertensive rats.

L C Rump1, K Wilde, P Schollmeyer.   

Abstract

Renal neurotransmission and its modulation by prostaglandin (PG) E2 (0.06 microM) and indomethacin (10 microM) was investigated in isolated kidneys of adult spontaneously hypertensive (SHR) and normotensive control (WKY) rats. After preincubation with [3H]-noradrenaline the renal nerves were stimulated. The stimulation induced (S-I) outflow of radioactivity was taken as an index of noradrenaline release. The S-I outflow of radioactivity from SHR and WKY kidneys was similar but S-I pressor responses were enhanced in kidneys of SHR. PGE2 inhibited and indomethacin enhanced the S-I outflow of radioactivity in kidneys of WKY and SHR to a similar extent. This inhibitory effect of PGE2 is due to activation of inhibitory prejunctional PGE2 receptors. Neuronally released noradrenaline stimulates a local formation of PGE2 which then transjunctionally inhibits noradrenaline release. Renal noradrenaline release in the adult SHR and its modulation by PGs is not altered. An enhanced postjunctional responsiveness of the renal vasculature may contribute to the maintenance of hypertension in the adult SHR.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268506      PMCID: PMC1368125          DOI: 10.1111/j.1365-2125.1990.tb05495.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

Review 1.  Regulation of noradrenaline release by presynaptic receptor systems.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

2.  Modulation of renal noradrenaline release by prejunctional receptor systems in vitro.

Authors:  L C Rump
Journal:  Clin Exp Pharmacol Physiol       Date:  1987-05       Impact factor: 2.557

Review 3.  Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension.

Authors:  T C Westfall; M J Meldrum
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

4.  Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.

Authors:  L C Rump; P Schollmeyer
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

5.  Renal sympathetic activity in spontaneously hypertensive rats and normotensive controls, as studied by three different methods.

Authors:  S Lundin; S E Ricksten; P Thorén
Journal:  Acta Physiol Scand       Date:  1984-02

Review 6.  Noradrenaline release and sympathetic nervous system activity.

Authors:  M D Esler; G J Hasking; I R Willett; P W Leonard; G L Jennings
Journal:  J Hypertens       Date:  1985-04       Impact factor: 4.844

Review 7.  Renal nerves in the pathogenesis of hypertension in experimental animals and humans.

Authors:  R E Katholi
Journal:  Am J Physiol       Date:  1983-07

8.  Modulation of norepinephrine release through alpha 1- and alpha 2-adrenoceptors in rat isolated kidney.

Authors:  L C Rump; H Majewski
Journal:  J Cardiovasc Pharmacol       Date:  1987-04       Impact factor: 3.105

  8 in total
  1 in total

1.  Activation of beta 2-adrenoceptors by isoprenaline and adrenaline enhances noradrenaline release in cortical kidney slices of young spontaneously hypertensive rats.

Authors:  L C Rump; M J Schuster; P Schollmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.